Navigation Links
EBI Ionic=® Spine Spacer System

ProductsEBI Ionic=® Spine Spacer System
Company Biomet, Inc.
Item EBI Ionic=® Spine Spacer System
Features Unique, open design allows for:
  • optimal bone graft placement
  • ingrowth
  • maximum postoperative radiographic assessment
  • Anatomical shape:

  • matches the vertebral body endplate
  • Optimized tooth design:

  • offers excellent endplate purchase
  • limits migration
  • Endplate-sparing device:

  • no reaming required
  • one-piece design with solid center column:
  • provides structural integrity
  • Versatile system offers:

  • a range of heights
  • two lordotic angles
  • maintenance and restoration of patient's normal lordosis
  • Description An innovative new system to help you meet the challenges of anterior spine surgery.

    The system's one-piece design creates a broad area for fusion to occur and enhances postoperative radiographic assessment. The slotted superior and inferior platforms facilitate bone growth around the central column and are flared outward for greater surface contact. The endplate fins help reduce implant migration. Available in various sizes and lordotic angles.

    Info Biomet, Inc.
    Customer Service: 1-800-526-2579
    Web site: http://www.ebimedical.com/

    Related medicine products :

    1. Spine-Tract Anterior Lumbar Retractor System
    2. Circular Spine Retractor System
    3. Spine-Tract Posterior Lumbar Retractor System
    4. Circular Spine Retractor
    5. Image-Trac Posterior Spine Retractor System
    6. Spine System Evolution
    7. CF-94 Spine Frame
    8. Fluoro-Spine with Instratrak 3500 - Spine
    9. Fluoro-Spine with Fluorotrak 3500
    10. SpineAssist
    11. EBI Ionic® Spine Spacer System
    ... The new Amsco 3080/3085 SP Bariatric ... width capacity and expanded surgical capabilities for ... extensions are rated for patients up to ... and easy attachment and full positioning capability. ...
    ... The new Amsco 3080/3085 SP Bariatric Foot ... capacity and expanded surgical capabilities for Amsco ... The Amsco Foot Extension is rated for ... designed for secure and easy attachment and ...
    ... The Pulsavac Plus System offers a ... Debridement System. High power efficiently clears bone ... Specific tips are available for hip and ... a wide range of pressure options for ...
    The Simpulse Solo Pulsed Lavage System requires minimal set up and has a Wide range of tips available for every orthopaedic procedure. It uses a separate suction lumen to reduce clogging and n ergono...
    Medicine Products:
    (Date:9/22/2014)... News) -- Teens and young adults at risk for ... help prevent risky sexual behaviors, according to new recommendations ... year, about 20 million new sexually transmitted infections such ... About half involve people between 15 and 24 years ... new report, published Sept. 22 in Annals of ...
    (Date:9/22/2014)... surprising new study pulls back the curtain on one ... in payment and income between physicians who perform operations, ... Contrary to perception, the research indicates, the physician payment ... other procedure-performing doctors. , The new findings counter the ... per minute explains why doctors who perform procedures often ...
    (Date:9/22/2014)... New York, NY (PRWEB) September 22, 2014 ... pain on the side of the hip , ... for hip bursitis treatment in Manhattan. This treatment is now offered ... bursitis, which is also called trochanteric bursitis, occurs when ... is a fluid-filled sac in the hip, between the ...
    (Date:9/22/2014)... By Steven Reinberg ... -- Pediatricians are urging that all children aged 6 months ... The American Academy of Pediatrics updated their influenza vaccine recommendations ... doses of vaccine to build immunity. The AAP also wants ... their kids the nasal spray vaccine instead of the flu ...
    (Date:9/22/2014)... patients undergoing breast cancer surgery require additional operations because ... in the initial operation. However, researchers at Brigham and ... developed that will help surgeons better distinguish cancerous breast ... repeat operations. , The study is ... the Proceedings of the National Academy of Sciences ...
    Breaking Medicine News(10 mins):Health News:Behavioral Counseling Urged for Teens, Young Adults at Risk for STDs 2Health News:Behavioral Counseling Urged for Teens, Young Adults at Risk for STDs 3Health News:Think the system for paying US doctors is rigged to favor surgeons? Study may surprise you 2Health News:Think the system for paying US doctors is rigged to favor surgeons? Study may surprise you 3Health News:Think the system for paying US doctors is rigged to favor surgeons? Study may surprise you 4Health News:DNR Clinic Offers Hip Bursitis Treatment in Manhattan 2Health News:DNR Clinic Offers Hip Bursitis Treatment in Manhattan 3Health News:Pediatricians Urge Flu Vaccine for All Kids 6 Months and Older 2Health News:Pediatricians Urge Flu Vaccine for All Kids 6 Months and Older 3Health News:The fine line between breast cancer and normal tissues 2
    ... 19 /PRNewswire-FirstCall/ - Notification of Year End,2007 Earnings Webcast ... (TSX: RBM) Year End 2007 Earnings Webcast and ... To listen to this Webcast and Conference Call ... To participate in the live conference call please dial ...
    ... Using the Canadian Light Source synchrotron, an international team led ... detailed structure of the enzyme the Norwalk virus uses to ... itself. The information is crucial to developing drugs that could ... viruses. , The Norwalk virus uses the enzyme, RNA ...
    ... (OTC,Bulletin Board: RXEI), a developer, manufacturer, and marketer of ... its,2007 year-end financial results in a conference call on ... Company will release its 2007 year-end financial results after ... call will be,RxElite CEO Jonathan Houssian, COO Earl E. ...
    ... ST. LOUIS, March 18 Sigma-Aldrich (Nasdaq:,SIAL) announced ... its $300 million,revolving credit facility established in December ... feature. Under the revised $450 million,revolving credit facility, ... and,$420 million will mature on December 11, 2012. ...
    ... The Pharmaceutical Care,Management Association (PCMA) issued the ... that are being,debated in Congress:, "PCMA ... drug,therapies is an important tool in promoting ... way with Pharmacy & Therapeutics,(P&T) committees and ...
    ... mental acuity may actually improve , , TUESDAY, March 18 ... treatment, head-and-neck cancer patients experience decreases in their physical ... quality of life, says a U.S. study. , ... that head and neck cancer treatment such as feeding ...
    Cached Medicine News:Health News:Scientists see Norwalk virus' Achilles heel 2Health News:RxElite Inc. Fourth Quarter and Year-End 2007 Earnings Release and Conference Call Notice 2Health News:Head and Neck Cancer Outcomes a Mixed Bag 2
    (Date:9/22/2014)... Research and Markets has ... Technologies (Radiofrequency, Ultrasound, Irreversible Electroporation, Cryotherapy, Microwave) Market ... offering. On the basis of ... has been divided into eight major segments, namely, ... hydromechanical ablation technologies. The light/laser ablation technology segment ...
    (Date:9/22/2014)... Sept. 22, 2014 /PRNewswire/-- CANTEL MEDICAL CORP. (NYSE: CMN ... fiscal 2014 ended July 31, 2014 on Monday, September 29 ... discuss the results at 11:00 AM ET. Participating in the ... Andrew A. Krakauer , President and CEO; Jorgen B. ... Sheldon , Senior Vice President, CFO and Treasurer; and ...
    (Date:9/22/2014)... NORTH CHICAGO, Ill. , Sept. 22, 2014 ... that data from several clinical studies evaluating potential ... be presented at the upcoming 2014 European Society ... in Madrid, Spain . Data ... study evaluating the safety and efficacy of veliparib ...
    Breaking Medicine Technology:Global Ablation Technologies (Radiofrequency, Ultrasound, Irreversible Electroporation, Cryotherapy, Microwave) Market - Forecasts to 2019 2Global Ablation Technologies (Radiofrequency, Ultrasound, Irreversible Electroporation, Cryotherapy, Microwave) Market - Forecasts to 2019 3Cantel Medical Corp. To Hold Conference Call To Discuss Results For Its Fourth Quarter And Fiscal 2014 Ended July 31, 2014 2AbbVie to Present Clinical Study Data on Potential New Oncology Medicines at the 2014 European Society of Medical Oncology Annual Meeting 2AbbVie to Present Clinical Study Data on Potential New Oncology Medicines at the 2014 European Society of Medical Oncology Annual Meeting 3AbbVie to Present Clinical Study Data on Potential New Oncology Medicines at the 2014 European Society of Medical Oncology Annual Meeting 4